ATAlicja Trzepizur

Alicja Trzepizur

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alicja Trzepizur has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Impact of Hyaluronic Acid-Based Therapy on Burn Wound Healing

    by Izabela Ochonska, Alicja Trzepizur, Zuzanna Socha, Dastin Misiaszek, Natalia Sałkowska, Dominik Zając, Maciej Łydka, Jan Gajewski, Grzegorz Machelski

    Burn injuries are among the most complex forms of skin trauma, characterized by disruption of tissue integrity, excessive inflammatory response, increased risk of infection, and impaired healing that often leads to scarring and functional impairment. Despite advances in surgical and supportive care, effective strategies to optimize both the rate and quality of burn wound healing remain limited, prompting increasing interest in biomaterial-based regenerative approaches.Hyaluronic acid (HA), a naturally occurring glycosaminoglycan of the extracellular matrix, has emerged as a multifunctional biomaterial with significant relevance in burn wound management. Its biological activity includes regulation of inflammation, promotion of cell migration and proliferation, stimulation of angiogenesis, and modulation of extracellular matrix remodeling. These effects are strongly influenced by molecular weight and receptor-mediated interactions, particularly via CD44 and RHAMM.This work provides an overview of HA biosynthesis, biological functions, and its role in burn wound healing, with emphasis on its mechanisms of action and clinical applications. A broad spectrum of HA-based systems is discussed, including topical formulations, hydrogels, impregnated dressings, dermal scaffolds, sponges, and combination therapies incorporating bioactive agents such as growth factors, polynucleotides, and platelet-rich plasma.The literature suggests that HA-based therapies may beneficially influence multiple phases of wound healing; however, current evidence remains heterogeneous and limited by a lack of large-scale randomized controlled trials in burn populations. Further research is required to define their optimal clinical use.

  • Open Access

    Current Therapeutic Strategies for Obesity in the Pediatric Population: A Literature Review

    by Julia Rokosz, Krzysztof Mazur, Sandra Michałek, Julianna Koczuk, Katarzyna Sładek, Alicja Trzepizur, Monika Spaczyńska-Kwiatkowska

    Background: Childhood obesity is a major public health problem in both developing and developed countries. It is a chronic, complex, and progressive disease influenced by multiple genetic, psychological, dietary, familial, environmental, and biological factors. It is associated with a wide range of short- and long-term multiorgan complications, many of which persist into adulthood, increasing the risk of chronic multimorbidity. Therefore, early prevention and appropriate treatment are essential. Aim: To review current therapeutic strategies for pediatric obesity, focusing on lifestyle and behavioral interventions, pharmacotherapy, and bariatric surgery, and to evaluate their effectiveness and clinical applicability. Materials and methods: A literature review was conducted using PubMed, the Cochrane Library, and Google Scholar, focusing mainly on studies published after 2020 addressing lifestyle, psychological, pharmacological, and surgical management of obesity in children and adolescents. Results: The therapeutic approach is holistic, based on sustainable lifestyle modification, including dietary changes, physical activity, reduced sedentary behavior, and family involvement. Cognitive-behavioral therapy is crucial in modifying maladaptive behaviors. Pharmacotherapy has expanded options, with GLP-1 receptor agonists (semaglutide, liraglutide) showing the greatest effectiveness, while orlistat, phentermine/topiramate, and setmelanotide may provide additional benefit. Bariatric surgery remains the most effective intervention for severe adolescent obesity, resulting in substantial and sustained weight loss. Conclusions: Management should be multidisciplinary, with individualized behavioral and psychological interventions as the foundation. Pharmacotherapy and bariatric surgery should be considered in selected patients with severe obesity or inadequate response to conservative treatment.

  • Open Access

    Sustaining the Quality of Sports Participation and Life Standards in Aging Men: A Systematic Review of Physical Activity and Urological Health Management

    by Dawid Studziński, Wiktoria Szkatuła, Karolina Osińska, Anna Kołcz, Michał Kulczak, Konrad Turczynowski, Kamil Turczynowski, Alicja Trzepizur, Jakub Pietrucha, Izabela Ochońska

    This systematic review formulates an organizational service framework integrating clinical urological data with sports management practices to mitigate disease-induced dropout among aging male athletes. Following PRISMA guidelines, a systematic search of PubMed (2021–2026) yielded 22 primary open-access articles evaluating physical activity, sedentary behaviors, and male urological or renal outcomes. High-volume cohort data confirms a robust inverse relationship between regular physical activity and the severity of lower urinary tract symptoms and erectile dysfunction, though extreme training volumes display a non-linear risk threshold. In clinical rehabilitation phases, supervised technological exercises paired with behavioral compliance models significantly accelerate post-surgical continence recovery. Longitudinally, overactive bladder symptoms serve as independent predictors of upper-limb grip strength decline and physical frailty. Sports enterprises can optimize service quality and member retention by moving from generic configurations toward age-appropriate, urologically sustainable exercise designs. Practical administrative interventions include expanding facility restroom accessibility to reduce public anxiety and embedding non-invasive urological screening metrics into routine physical assessments to preserve lifelong functional longevity.

  • Open Access

    Current Treatment Strategies for Irritable Bowel Syndrome - A Literature Review

    by Sandra Michałek, Julia Rokosz, Katarzyna Sładek, Julianna Koczuk, Krzysztof Mazur, Alicja Trzepizur, Bartosz Wnorowski

    Background. Irritable bowel syndrome is one of the most common chronic gastrointestinal disorders. This disease is diagnosed worldwide, although it is much more common in developed countries. The main role in the development of the disease is attributed to dysfunction of the brain-gut axis and factors such as intestinal microbiota dysbiosis and prolonged exposure to stress. The symptoms significantly reduce the quality of life of patients, which is why it is so important to develop clear recommendations for better control of the condition. Aim. The aim of this study was to analyse and summarise current pharmacological and non-pharmacological strategies for treating irritable bowel syndrome. Materials and methods. A review of the literature available in the PubMed, Google Scholar and Cochrane databases was conducted. Articles published between 2012-2025 were considered. Publications of low methodological quality and those containing incomplete data were excluded. Results. According to research, the best dietary intervention is a low-FODMAP diet, but it should be followed under the supervision of an experienced dietitian. Probiotics should be considered as first-line medications. A growing number of publications point to the beneficial effects of psychotherapy, regular moderate-intensity physical activity, and healthy eating habits, especially regular consumption of small meals. The impact of quality sleep and stress management skills on prolonging IBS remission is also emphasized, but the scientific evidence is not yet strong enough. Conclusions. Changes in diet and eating habits have been shown to be important in reducing symptoms and prolonging remission. There are many pharmacological options available, but there are no clear guidelines due to the complex pathomechanism of the disease. Currently, probiotics are the most recommended treatment. Herbal therapies, psychotherapy, mindfulness techniques, physical activity should be considered as additional support.

  • Open Access

    Therapeutic Hypothermia in Neonatal Hypoxic-Ischemic Encephalopathy: Current Evidence and Clinical Practice- A Literature Review

    by Alicja Trzepizur, Monika Spaczyńska-Kwiatkowska, Zuzanna Socha, Izabela Ochońska, Dawid Studziński, Sandra Michałek, Julia Pakulska

    Background: Hypoxic-ischemic encephalopathy (HIE) remains a major cause of neonatal mortality and long term neurodevelopmental impairment worldwide. Therapeutic hypothermia (TH) is currently the standard of care for newborns with moderate-to-severe HIE; however, several aspects of its use remain controversial. Aim: The aim of this paper is to present the current state of knowledge regarding the use of therapeutic hypothermia in newborns with HIE with particular emphasis on mechanisms of action, eligibility criteria, course of therapy, clinical efficacy and adverse effects, as well as to discuss current controversies and directions for further research. Material and methods: A narrative literature review was conducted using the PubMed database to identify studies on therapeutic hypothermia in newborns with hypoxic-ischemic encephalopathy. Publications from the past 11 years were included with particular emphasis on studies published within the last 5 years. Relevant original articles and review papers focusing on clinical outcomes and effectiveness were analyzed. Results: Therapeutic hypothermia reduces the risk of death and severe neurodevelopmental disability in newborns with moderate and severe HIE. Its neuroprotective effects are associated with reduced cerebral metabolism, decreased oxidative stress, modulation of inflammatory response, and inhibition of apoptosis. However, its efficacy in mild HIE and in preterm infants remains inconclusive. The most common adverse effects include cardiovascular, metabolic, and hematological disturbances requiring close monitoring. Conclusions: Therapeutic hypothermia is an effective and relatively safe treatment for HIE; however, it does not completely eliminate the risk of neurodevelopmental impairment. Further research is needed to optimize treatment protocols, expand its use to other populations and evaluate combination therapies.